NewAmsterdam Pharma N.V. (NAMSW)
undefined
undefined%
At close: undefined
13.02
-3.41%
After-hours Dec 13, 2024, 03:03 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -176.94M -78.05M -28.60M -5.75M
Depreciation & Amortization 49.00K 72.00K 14.00K 1K
Stock-Based Compensation 24.57M 4.12M 1.24M -
Other Working Capital 796.00K 11.46M -16.97K -576.30K
Other Non-Cash Items 5.23M 70.57M -7.00K 306.00K
Deferred Income Tax - - -1.44M -
Change in Working Capital 5.87M 11.46M 3.82M -528.00K
Operating Cash Flow -141.22M 7.97M -25.16M -5.97M
Capital Expenditures -24.00K -13.00K -20.00K -13.00K
Acquisitions - - - -
Purchase of Investments - - - -
Sales Maturities Of Investments - - - -
Other Investing Acitivies -24.00K 728.00K - -112.79M
Investing Cash Flow -24.00K 715.00K -20.00K -13.00K
Debt Repayment - 747.00K - 13.92M
Common Stock Repurchased - - - -
Dividend Paid - - - -
Other Financial Acitivies 8.91M -5.79M -15.71M -2.60M
Financial Cash Flow 8.91M 375.18M 68.99M 11.32M
Net Cash Flow -127.28M 385.43M 45.23M 5.36M
Free Cash Flow -141.24M 7.96M -25.18M -5.98M